A new agent, AZD9291, showed promising clinical activity and progression-free survival in a study of patients with advanced stage, EGFR mutation-positive NSCLC.

Data from the LUX-Lung 8 trial showed afatinib outperformed erlotinib with regard to both progression-free and overall survival in squamous cell lung cancer.

Pembrolizumab demonstrated a 24.8% overall response rate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Health care is a big target for data breaches, according to experts at SIIM 2015.

Immediate ADT improved overall survival compared with delayed ADT in prostate cancer patients with a rising prostate-specific antigen level.

Elective neck lymph node surgery for patients with early oral cancer reduces the risk of cancer recurrence and improves survival.


Rates of severe mental illness in children and adolescents have dropped 16% since 1996, according to a new study. The lead author explains possible reasons for this surprising finding and concludes: "We're moving in the right direction!"

A new study of amyloid PET brings imaging to the forefront of research for Alzheimer's disease.


Subscribe to Cancer Network RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.